Paragon Capital Management (Kansas)’s Thermo Fisher Scientific TMO Stock Holding History

Paragon Capital Management (Kansas)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-591	Closed	-$299K	–	58
2023 Q3	$299K	Buy	591 +66	+13%	+$35.2K	0.18%	40
2023 Q2	$274K	Sell	525 -3	-0.6%	-$1.62K	0.16%	44
2023 Q1	$304K	Buy	528 +3	+0.6%	+$1.69K	0.18%	39
2022 Q4	$289K	Hold	525	–	–	0.18%	39
2022 Q3	$266K	Hold	525	–	–	0.17%	40
2022 Q2	$285K	Hold	525	–	–	0.17%	42
2022 Q1	$310K	Buy	+525	New	+$302K	0.16%	44
2021 Q3	–	Sell	-525	Closed	-$265K	–	66
2021 Q2	$265K	Hold	525	–	–	0.13%	55
2021 Q1	$256K	Hold	525	–	–	0.13%	58
2020 Q4	$245K	Hold	525	–	–	0.13%	49
2020 Q3	$232K	Buy	+525	New	+$217K	0.13%	49
2020 Q2	–	Sell	-500	Closed	-$142K	–	158
2020 Q1	$142K	Buy	+500	New	+$158K	0.1%	54
2019 Q4	–	Sell	-533	Closed	-$155K	–	62
2019 Q3	$155K	Hold	533	–	–	0.08%	54
2019 Q2	$157K	Hold	533	–	–	0.07%	58
2019 Q1	$146K	Buy	+533	New	+$133K	0.07%	60

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Paragon Capital Management (Kansas)'s TMO Position: Q4 2023 in Review

Paragon Capital Management (Kansas) sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 591 shares — an estimated $299K sold.

Paragon Capital Management (Kansas) first reported a position in TMO in Q1 2019 and held it in 15 quarters. The position peaked at $310K in Q1 2022. 2,490 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Paragon Capital Management (Kansas) reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Paragon Capital Management (Kansas) sold 591 Thermo Fisher Scientific shares in Q4 2023, an estimated $299K.
Paragon Capital Management (Kansas) first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 15 quarters.
Paragon Capital Management (Kansas)'s Thermo Fisher Scientific position peaked at $310K in Q1 2022.
2,490 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q4 2023, filed 13 Feb 2024.